Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisolone for Postoperative Pain in Symptomatic Irreversible Pulpitis
NCT02819648Phase 4Completed
- Sponsor
- Cairo University
- Start
- Jun 2012
- Primary completion
- Jan 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of prednisolone in irreversible pulpitis, sponsored by Cairo University. Primary endpoint: Postoperative pain at 24 hours. Started Jun 2012; status: completed.
02
Drugs
prednisolone
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on NCT02819648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02819648.